이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

AS Latvijas Juras medicinas centrs 대차 대조표 상태

재무 상태 기준 확인 5/6

AS Latvijas Juras medicinas centrs 의 총 주주 지분은 €6.3M 이고 총 부채는 €0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 €9.0M 및 €2.7M 입니다.

주요 정보

부채 비율

€0

부채

이자 보상 비율	n/a
현금	€695.74k
주식	€6.29m
총 부채	€2.71m
총 자산	€9.01m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

AS Latvijas Juras medicinas centrs' (MUN:UOM) Dividend Will Be Increased To €0.20

Jun 23

Investors Shouldn't Be Too Comfortable With AS Latvijas Juras medicinas centrs' (MUN:UOM) Robust Earnings

Jun 06

A Look At The Intrinsic Value Of A/S Latvijas Juras medicinas centrs (MUN:UOM)

Jun 01

Could A/S Latvijas Juras medicinas centrs (MUN:UOM) Have The Makings Of Another Dividend Aristocrat?

Feb 17

Will Weakness in A/S Latvijas Juras medicinas centrs' (MUN:UOM) Stock Prove Temporary Given Strong Fundamentals?

Dec 24

재무 상태 분석

단기부채: UOM 의 단기 자산 ( €1.3M )은 단기 부채( €1.7M ).

장기 부채: UOM 의 단기 자산( €1.3M )이 장기 부채( €985.9K ).

부채 대 자본 내역 및 분석

부채 수준: UOM 부채가 없습니다.

부채 감소: UOM 5년 전에 부채가 없었습니다.

부채 범위: UOM 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: UOM 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

AS Latvijas Juras medicinas centrs 대차 대조표 상태

재무 상태 기준 확인 5/6

주요 정보

최근 재무 상태 업데이트

Recent updates

New major risk - Revenue and earnings growth

AS Latvijas Juras medicinas centrs, Annual General Meeting, Jun 12, 2024

AS Latvijas Juras Medicinas Centrs Announces Resignation of Anatolijs Ahmetovs from the Management Board

Full year 2023 earnings released: €0.018 loss per share (vs €0.69 profit in FY 2022)

Third quarter 2023 earnings released: EPS: €0.35 (vs €0.068 in 3Q 2022)

Upcoming dividend of €0.10 per share at 0.9% yield

Second quarter 2023 earnings released: €0.082 loss per share (vs €0.11 loss in 2Q 2022)

AS Latvijas Juras Medicinas Centrs Announces Dividend Payment, Payable December 1, 2023

First quarter 2023 earnings released: €0.17 loss per share (vs €0.47 profit in 1Q 2022)

AS Latvijas Juras medicinas centrs, Annual General Meeting, Jun 13, 2023

AS Latvijas Juras medicinas centrs to Report Nine Months, 2023 Results on Nov 20, 2023

Third quarter 2022 earnings released: EPS: €0.068 (vs €0.36 in 3Q 2021)

Second quarter 2022 earnings released: €0.11 loss per share (vs €0.16 profit in 2Q 2021)

AS Latvijas Juras medicinas centrs' (MUN:UOM) Dividend Will Be Increased To €0.20

AS Latvijas Juras medicinas centrs to Pay Dividend, Payable on June 28, 2022

Upcoming dividend of €0.20 per share

Investors Shouldn't Be Too Comfortable With AS Latvijas Juras medicinas centrs' (MUN:UOM) Robust Earnings

First quarter 2022 earnings released

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: EPS €0.16 (vs €0.098 in 2Q 2020)

Inaugural dividend of €0.07 per share

First quarter 2021 earnings released: EPS €0.25 (vs €0.099 in 1Q 2020)

A Look At The Intrinsic Value Of A/S Latvijas Juras medicinas centrs (MUN:UOM)

Full year 2020 earnings released: EPS €0.34 (vs €0.20 in FY 2019)

Investor sentiment improved over the past week

Could A/S Latvijas Juras medicinas centrs (MUN:UOM) Have The Makings Of Another Dividend Aristocrat?

Investor sentiment improved over the past week

New 90-day high: €8.00

Will Weakness in A/S Latvijas Juras medicinas centrs' (MUN:UOM) Stock Prove Temporary Given Strong Fundamentals?

A/S Latvijas Juras medicinas centrs to Report First Half, 2021 Results between Aug 23, 2021 and Aug 27, 2021

New 90-day low: €6.30

Investor sentiment deteriorated over the past week

Third quarter 2020 earnings released: EPS €0.26

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기